Allergan Announced That The US FDA Has Approved DALVANCE Supplementary New Drug Application (sNDA)

25 Jan
FDA approves Allergan's sNDA to update label for DALVANCE (dalbavancin) for injection

Allergan announced that the US FDA has approved the company’s supplemental New Drug Application (sNDA) Update injection DALVANCE Allergan announced that the US FDA has approved the supplemental new drug application DALVANCE <wbr> (sNDA) (dalbavancin) drug label. Extended label will … Read More »

Researchers Have Used CRISPR To Treat an Adult Mouse Model of Duchenne Muscular Dystrophy

4 Jan
Duchenne-muscular-dystrophy

Duchenne muscular dystrophy is caused by genetic factors in progressive skeletal muscle weakness is characterized by a set of primary skeletal muscle necrosis disease, major clinical manifestations of progressive skeletal muscle atrophy and distribution of various degrees of worsening and … Read More »

Bacillus Cereus Become Fully Functioning Bacteria May Provide Alternative Explanation For Antibiotic Resistance

29 Dec
Bacillus_cereus

Bacillus cereus can produce antibacterial substances, inhibit the propagation of harmful microorganisms, degradation of soil nutrients, improve the ecological environment. Can produce bacterial proteases; it can be used for degumming hemp, a variety of antibiotics, bacteria antibacterial activity assay. The … Read More »

A novel class of antimicrobials that fighting methicillin-resistant Staphylococcus aureus

2 Dec
A novel class of antimicrobials that fighting methicillin-resistant Staphylococcus aureus

Antibiotics are a class of secondary metabolites with anti-pathogen or other activity by the micro-organisms (including bacteria, fungi, actinomycetes genus) or higher plants and animals in the process of life arising, can interfere with the development of other living cells … Read More »